Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors

被引:20
|
作者
Proska, J [1 ]
Tucek, S [1 ]
机构
[1] ACAD SCI CZECH REPUBL,INST PHYSIOL,CR-14220 PRAGUE,CZECH REPUBLIC
关键词
muscarinic receptor; heart; allosteric control; allosteric interaction; eburnamonine; vincamine; alcuronium; strychnine;
D O I
10.1016/0014-2999(96)00169-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It was discovered recently that alcuronium and strychnine (which is a precursor of alcuronium) allosterically increase the affinity of cardiac muscarinic receptors for the antagonist, N-methylscopolamine. We have now investigated the effects of l-eburnamonine and vincamine, which are both closely related to strychnine. In experiments on rat heart atria, l-eburnamonine was found to increase the binding of [H-3]N-methylscopolamine with Ehlert's cooperativity coefficient alpha = 0.35, which indicates that the strength of its allosteric action is close to that of alcuronium and strychnine (alpha = 0.31 and 0.44, respectively). However, the affinity of l-eburnamonine for the cardiac muscarinic receptors is lower than the affinities of alcuronium and strychnine (k(AR) = 22.6 mu M, 0.15 mu M, and 3.4 mu M, respectively). In spite of its extremely close similarity to l-eburnamonine, vincamine has a negative allosteric effect on the binding of [H-3]N-methylscopolamine (alpha = 4.1; K-AR = 22.8 mu M). It is likely that a systematic investigation of the allosteric effects of the analogues of strychnine will not only yield new allosteric effecters on muscarinic receptors, but also clarify the structural features responsible for the direction (positive or negative) of their allosteric effect.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [31] Anti-muscarinic autoantibodies and vagal modulation in Chagas disease:: Positive allosteric modulators vs desensitization and downregulation of M2 cardiac acetylcholine receptors
    Davila, Diego F.
    Donis, Jose H.
    Davila, Leonardo A.
    Odreman, Wilmer A.
    Arata de Bellabarba, Gabriela
    Villarroel, Vanesa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 123 (03) : 328 - 329
  • [32] DISTRIBUTION OF MUSCARINIC ACETYLCHOLINE RECEPTORS IN AMPHIBIAN CARDIAC-MUSCLE
    HARTZELL, HC
    NATURE, 1979, 278 (5704) : 569 - 571
  • [33] Allosteric regulation of muscarinic receptors
    Birdsall, NJM
    Lazareno, S
    Matsui, H
    CHOLINERGIC MECHANISMS: FROM MOLECULAR BIOLOGY TO CLINICAL SIGNIFICANCE, 1996, 109 : 147 - 151
  • [34] MUSCARINIC ACTION OF ACETYLCHOLINE
    CURTIS, DR
    FELIX, D
    NATURE, 1971, 234 (5328) : 355 - &
  • [35] 2 ALLOSTERIC MODULATORS INTERACT AT A COMMON SITE ON CARDIAC MUSCARINIC RECEPTORS
    ELLIS, J
    SEIDENBERG, M
    MOLECULAR PHARMACOLOGY, 1992, 42 (04) : 638 - 641
  • [36] Binding and functional characterisation of allosteric agonists at M2 muscarinic acetylcholine receptors
    Gregory, Karen Joan
    Hall, Nathan E.
    Sexton, Patrick M.
    Christopoulos, Arthur
    FASEB JOURNAL, 2008, 22
  • [37] Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators
    Berizzi, Alice E.
    Gentry, Patrick R.
    Rueda, Patricia
    Den Hoedt, Sandra
    Sexton, Patrick M.
    Langmead, Christopher J.
    Christopoulos, Arthur
    MOLECULAR PHARMACOLOGY, 2016, 90 (04) : 427 - 436
  • [38] (±)Epibatidine increases acetylcholine release partly through an action on muscarinic receptors
    Kommalage, M
    Höglund, AU
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (05) : 238 - 244
  • [39] Activation and allosteric modulation of a muscarinic acetylcholine receptor
    Andrew C. Kruse
    Aaron M. Ring
    Aashish Manglik
    Jianxin Hu
    Kelly Hu
    Katrin Eitel
    Harald Hübner
    Els Pardon
    Celine Valant
    Patrick M. Sexton
    Arthur Christopoulos
    Christian C. Felder
    Peter Gmeiner
    Jan Steyaert
    William I. Weis
    K. Christopher Garcia
    Jürgen Wess
    Brian K. Kobilka
    Nature, 2013, 504 : 101 - 106
  • [40] ALLOSTERIC ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE-RECEPTOR
    LEE, NH
    ELFAKAHANY, EE
    BIOCHEMICAL PHARMACOLOGY, 1991, 42 (02) : 199 - 205